Literature DB >> 12951281

Assessing weight-related quality of life in obese persons with type 2 diabetes.

Ronette L Kolotkin1, Ross D Crosby, G Rhys Williams.   

Abstract

Because approximately 80% of individuals with type 2 diabetes are obese, we examined weight-related QOL in obese persons with diabetes using the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) questionnaire. Study participants were enrolled in a clinical trial for an obesity medication or a clinical study of gastric bypass surgery. Psychometric properties of the IWQOL-Lite were evaluated separately for obese persons with (n = 225) and without (n = 972) type 2 diabetes. Internal consistency reliabilities were similar for persons with and without diabetes (0.981 versus 0.980). Correlations between IWQOL-Lite scores and body mass index were significant and comparable for persons with and without diabetes. The IWQOL-Lite factor structure was similar for both the diabetic and non-diabetic subjects and consistent with earlier studies. There was no difference between diabetic and non-diabetic subjects on weight-related QOL as measured by the IWQOL-Lite; however, subjects in this study had more impaired weight-related QOL relative to a reference sample of overweight/obese community persons. We recommend the use of weight-related QOL measures in addition to generic and diabetes-specific measures when assessing quality of life in type 2 diabetes, particularly when patients are overweight or obese.

Entities:  

Mesh:

Year:  2003        PMID: 12951281     DOI: 10.1016/s0168-8227(03)00113-x

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  10 in total

1.  Relation of health-related quality of life to metabolic syndrome, obesity, depression and comorbid illnesses.

Authors:  M L Vetter; T A Wadden; J Lavenberg; R H Moore; S Volger; J L Perez; D B Sarwer; A G Tsai
Journal:  Int J Obes (Lond)       Date:  2010-11-02       Impact factor: 5.095

2.  Development and Evaluation of the Quality of Life for Obesity Surgery (QOLOS) Questionnaire.

Authors:  Astrid Müller; Ross D Crosby; Janine Selle; Alexandra Osterhus; Hinrich Köhler; Julian W Mall; Thorsten Meyer; Martina de Zwaan
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

3.  Predictors of weight loss at 1 year after laparoscopic adjustable gastric banding and the role of presurgical quality of life.

Authors:  S A Saboor Aftab; L Halder; M K Piya; N Reddy; I Fraser; V Menon; S Bridgwater; D Kendrick; S Kumar; T M Barber
Journal:  Obes Surg       Date:  2014-06       Impact factor: 4.129

Review 4.  Health-related quality of life among adults with diabetes.

Authors:  Susan L Norris
Journal:  Curr Diab Rep       Date:  2005-04       Impact factor: 4.810

5.  Utilities and disutilities for attributes of injectable treatments for type 2 diabetes.

Authors:  Kristina S Boye; Louis S Matza; Kimberly N Walter; Kate Van Brunt; Andrew C Palsgrove; Aodan Tynan
Journal:  Eur J Health Econ       Date:  2010-03-12

6.  Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment.

Authors:  Jennie H Best; Richard R Rubin; Mark Peyrot; Yan Li; Ping Yan; Jaret Malloy; Louis P Garrison
Journal:  Diabetes Care       Date:  2011-02       Impact factor: 19.112

7.  Weight regain after Roux-en-Y gastric bypass has a large negative impact on the Bariatric Quality of Life Index.

Authors:  Pichamol Jirapinyo; Barham K Abu Dayyeh; Christopher C Thompson
Journal:  BMJ Open Gastroenterol       Date:  2017-09-11

Review 8.  Patient-reported outcome measures for assessing health-related quality of life in people with type 2 diabetes: A systematic review.

Authors:  Marlous Langendoen-Gort; Lenka Groeneveld; Cecilia A C Prinsen; Joline W Beulens; Petra J M Elders; Ilana Halperin; Geetha Mukerji; Caroline B Terwee; Femke Rutters
Journal:  Rev Endocr Metab Disord       Date:  2022-07-02       Impact factor: 9.306

9.  Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily.

Authors:  J H Best; K S Boye; R R Rubin; D Cao; T H Kim; M Peyrot
Journal:  Diabet Med       Date:  2009-07       Impact factor: 4.359

10.  Performance of the Malay Audit of Diabetes Dependent Quality of Life-18 and Associates of Quality of Life among Patients with Type 2 Diabetes Mellitus from Major Ethnic Groups of Malaysia.

Authors:  Aqil M Daher; Syed Hassan A AlMashoor; Than Winn
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.